Hepatocellular Carcinoma Risk, Outcomes, and Screening After Hepatitis C Eradication

Hepatocellular Carcinoma Risk, Outcomes, and Screening After Hepatitis C Eradication

Bibliographic Details
Main Authors:	Roberta D’Ambrosio, George N. Ioannou
Format:	Article
Language:	English
Published:	Wolters Kluwer Health/LWW 2021-09-01
Series:	Hepatology Communications
Online Access:	https://doi.org/10.1002/hep4.1733

Similar Items

Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus
by: Nobuharu Tamaki, et al.
Published: (2022-03-01)

Clinical and Molecular Basis of Hepatocellular Carcinoma after Hepatitis C Virus Eradication
by: Natsumi Oe, et al.
Published: (2022-04-01)

Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals
by: Hye Won Lee, et al.
Published: (2020-11-01)

Outcomes and Follow-Up after Hepatitis C Eradication with Direct-Acting Antivirals
by: Erica Nicola Lynch, et al.
Published: (2023-03-01)

Screening for Hepatocellular Carcinoma in Patients with Hepatitis B
by: Yashasavi Sachar, et al.
Published: (2021-07-01)

Stratification of Hepatocellular Carcinoma Risk Following HCV Eradication or HBV Control
by: Pierre Nahon, et al.
Published: (2021-01-01)

Long-Term Outcomes and Evaluation of Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Eradication by Direct-Acting Antiviral Treatment: All Kagawa Liver Disease Group (AKLDG) Study
by: Joji Tani, et al.
Published: (2021-05-01)

Hepatitis C Virus and Hepatocellular Carcinoma
by: Masao Omata, et al.
Published: (2013-01-01)

Screening for Hepatocellular Carcinoma in Chronic Hepatitis B: An Update
by: James Lok, et al.
Published: (2021-07-01)

Role of LI-RADS Indeterminate Observations in the Risk of Hepatocellular Carcinoma after HCV Eradication with Direct-Acting Antivirals
by: Federica Vernuccio, et al.
Published: (2022-05-01)

Cure in Chronic Hepatitis C! Does it Prevent the Risk of Hepatocellular Carcinoma?
by: Mustafa Kemal ÇELEN, et al.
Published: (2018-06-01)

Eradication of Hepatitis C Virus Is Associated With Reduction in Hematologic Malignancies: Major Differences Between Interferon and Direct‐Acting Antivirals
by: George N. Ioannou, et al.
Published: (2019-08-01)

Significant Decrease in the Prevalence of Anxiety and Depression after Hepatitis C Eradication
by: Justyna Slonka, et al.
Published: (2022-05-01)

Clinicopathologic characteristics and outcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection
by: Abdulrahman A. Aljumah, et al.
Published: (2018-09-01)

Hepatic decompensation after transarterial radioembolization: A retrospective analysis of risk factors and outcome in patients with hepatocellular carcinoma
by: Marlene Reincke, et al.
Published: (2022-11-01)

Regression of liver fibrosis and hepatocellular carcinoma development after HCV eradication with oral antiviral agents
by: Hae Won Yoo, et al.
Published: (2022-01-01)

Immunological Mechanisms for Hepatocellular Carcinoma Risk after Direct-Acting Antiviral Treatment of Hepatitis C Virus Infection
by: Pil Soo Sung, et al.
Published: (2021-01-01)

Impact of cigarette smoking on outcome of hepatocellular carcinoma after surgery in patients with hepatitis B.
by: Xu-Feng Zhang, et al.
Published: (2014-01-01)

The Challenging Road to Hepatitis C Virus Eradication
by: Isidoro Martínez, et al.
Published: (2021-02-01)

Hepatocellular Carcinoma Prevention in the Era of Hepatitis C Elimination
by: Jeffrey V. Lazarus, et al.
Published: (2023-09-01)

Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus.
by: Yoshihiko Tachi, et al.
Published: (2015-01-01)

Screening for hepatocellular carcinoma
by: Jarosław Koza, et al.
Published: (2017-11-01)

Changes in Components of Metabolic Syndrome after Antiviral Eradication in Hepatitis C Virus Infection
by: Anca Trifan, et al.
Published: (2023-02-01)

Low Incidence of Hepatocellular Carcinoma after Antiviral Therapy in Patients with Chronic Hepatitis C and Hemophilia
by: In Jung Kim, et al.
Published: (2022-03-01)

Long-Term Survival and Curative-Intent Treatment in Hepatitis B or C Virus-Associated Hepatocellular Carcinoma Patients Diagnosed during Screening
by: Francesco Izzo, et al.
Published: (2022-11-01)

Metformin and Hepatocellular Carcinoma Risk Reduction in Diabetic Patients with Chronic Hepatitis C: Fact or Fiction?
by: Marco Sacco, et al.
Published: (2023-12-01)

Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy
by: Zheng Z, et al.
Published: (2023-11-01)

Tenofovir vs. Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma after Radiofrequency Ablation
by: Zili Hu, et al.
Published: (2022-03-01)

Hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma
by: Camillo Porta
Published: (2011-12-01)

Liver fibrosis assessment by transient elastography in patients with liver cirrhosis after hepatitis C virus eradication
by: E. A. Nabatchikova, et al.
Published: (2020-03-01)

Liver Lipids of Patients with Hepatitis B and C and Associated Hepatocellular Carcinoma
by: Elisabeth M. Haberl, et al.
Published: (2021-05-01)

Hepatocellular carcinoma in patients cured of chronic hepatitis C: Minimal steatosis
by: Chiara Rocha, et al.
Published: (2023-05-01)

Hepatitis C Virus Network Based Classification of Hepatocellular Cirrhosis and Carcinoma
by: Huang, Tao, et al.
Published: (2012)

Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma
by: Lorenz Kuske, et al.
Published: (2012-07-01)

Assessment of Liver Stiffness Regression and Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients after Treatment with Direct-Acting Antiviral Drugs
by: Martynas Ridziauskas, et al.
Published: (2021-02-01)

Hepatitis D Virus and Hepatocellular Carcinoma
by: Patrizia Farci, et al.
Published: (2021-05-01)

Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C Treated with Direct-Acting Antivirals
by: Cassia Leal, et al.
Published: (2023-01-01)

Study on the Value of Oligosaccharide Chain and Alpha-fetoprotein for Risk Screening and Diagnosis of Hepatitis B Virus-related Hepatocellular Carcinoma
by: ZHANG Yun, CAI Xinyi, DING Jingnuo, LU Shengwei, CHEN Cuiying, WU Tingting, ZHANG Junli, ZHAO Weifeng
Published: (2024-05-01)

Hepatocellular Carcinoma and Hepatitis: Advanced Diagnosis and Management with a Focus on the Prevention of Hepatitis B-Related Hepatocellular Carcinoma
by: Soo Ryang Kim, et al.
Published: (2023-10-01)

Viral Hepatitis and Hepatocellular Carcinoma: State of the Art
by: Toofan Datfar, et al.
Published: (2021-10-01)